Vitamin d3 drug
Pro Research Analysisby 
Searched over 200M research papers
The Role of Vitamin D3 in Various Health Conditions
High-Dose Vitamin D3 in Pulmonary Tuberculosis
Vitamin D3 Supplementation and Tuberculosis Outcomes
High-dose vitamin D3 supplementation has been investigated for its potential to improve outcomes in individuals with pulmonary tuberculosis. A study conducted in Tbilisi, Georgia, involved 199 individuals with pulmonary tuberculosis who were given either high-dose vitamin D3 or a placebo alongside standard antituberculosis drugs. The results showed that while vitamin D3 effectively corrected vitamin D deficiency, it did not significantly improve the rate of sputum Mycobacterium tuberculosis clearance over 16 weeks compared to the placebo group1.
Vitamin D3 and HIV-Related Pulmonary Tuberculosis
Impact on Mortality and Tuberculosis Incidence
In a randomized, double-blind, placebo-controlled trial conducted in Dar es Salaam, Tanzania, the effect of vitamin D3 supplementation on mortality and the incidence of pulmonary tuberculosis among adults initiating antiretroviral therapy (ART) was assessed. The study found no significant difference in mortality rates or the incidence of pulmonary tuberculosis between the vitamin D3 and placebo groups over a one-year follow-up period2.
Vitamin D3 in Chronic Obstructive Pulmonary Disease (COPD)
Prevention of Exacerbations and Infections
A multicenter trial in the UK evaluated whether vitamin D3 supplementation could reduce the incidence of moderate or severe COPD exacerbations and upper respiratory infections. The study concluded that vitamin D3 did not significantly affect the time to first moderate or severe exacerbation or upper respiratory infection. However, a subgroup analysis revealed that vitamin D3 was protective against exacerbations in patients with baseline vitamin D levels below 50 nmol/L3.
Vitamin D3 and Cancer
Antiproliferative Effects and Analog Development
Vitamin D3, particularly its active form 1,25-dihydroxyvitamin D3, has been shown to inhibit the proliferation and stimulate the differentiation of both normal and malignant cells. However, the high doses required for these effects can lead to hypercalcemia. Consequently, various structural analogs of 1,25-dihydroxyvitamin D3 have been developed to minimize these side effects while retaining antiproliferative properties. These analogs have shown promise in preclinical cancer models, although none are currently used clinically for cancer treatment4.
Vitamin D3 in In Vitro Fertilization (IVF)
Effect on Clinical Pregnancy Rates
The SUNDRO trial investigated whether a single high dose of vitamin D3 could improve clinical pregnancy rates in women undergoing IVF. The study found no significant improvement in clinical pregnancy rates or secondary outcomes such as miscarriage and live birth rates in the vitamin D3 group compared to the placebo group5.
Immunomodulatory Effects of Vitamin D3
Priming Dendritic Cells and Treg Development
Vitamin D3 and its metabolites, particularly calcidiol, have been shown to prime dendritic cells to promote the development of IL-10-producing regulatory T cells (Tregs). This immunomodulatory effect suggests potential therapeutic applications in treating autoimmune and allergic diseases, as calcidiol induces Tregs with sustained IFN-γ production, which can counterbalance Th2-dominated immune responses6.
Vitamin D3 in Chronic Kidney Disease
Renal Fibrosis and TGF-β1/Smad3 Pathway
High-dose vitamin D3 has demonstrated antifibrotic effects in a rat model of chronic kidney disease. The treatment reduced serum creatinine, urea nitrogen, and urine protein levels, and attenuated renal fibrosis by inhibiting the TGF-β1/Smad3 signaling pathway. These findings suggest that vitamin D3 could be a potential therapeutic agent for managing chronic kidney disease7.
Vitamin D3 Metabolism and Drug Interactions
CYP3A11 Activity and Drug Metabolism
Vitamin D3 has been shown to enhance the activity of the enzyme CYP3A11, which is involved in drug metabolism. This effect was observed in a study where vitamin D3 increased the expression of CYP3A11 in the liver and colon of rats, leading to altered metabolism of the drug midazolam. These findings highlight the importance of considering potential drug interactions when administering high doses of vitamin D38.
Conclusion
Vitamin D3 plays a multifaceted role in various health conditions, from pulmonary diseases and chronic kidney disease to its potential in cancer therapy and immunomodulation. While high-dose vitamin D3 supplementation can correct deficiencies, its efficacy in improving clinical outcomes varies across different conditions. Further research is needed to fully understand the therapeutic potential and optimal use of vitamin D3 and its analogs.
Sources and full results
Most relevant research papers on this topic
High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial.
High-dose vitamin D3 safely corrected vitamin D deficiency but did not improve sputum Mtb clearance rate over 16 weeks in this pulmonary tuberculosis cohort.
RCT
Very Rigorous Journal
Highly CitedEfficacy of vitamin D3 supplementation for the prevention of pulmonary tuberculosis and mortality in HIV: a randomised, double-blind, placebo-controlled trial.
Vitamin D3 supplementation did not significantly reduce the risk of mortality or pulmonary tuberculosis in adults living with HIV initiating antiretroviral therapy.
RCT
Large Human Trial
Rigorous JournalVitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial.
Vitamin D3 supplementation protects against moderate or severe COPD exacerbations in patients with low vitamin D levels, but not upper respiratory infections.
RCTRigorous JournalHighly CitedThe future of vitamin D analogs
Vitamin D analogs show potential in reducing cancer cell proliferation and promoting differentiation, but currently lack clinical approval for cancer treatment.
Highly CitedSingle oral dose of vitamin D3 supplementation prior to in vitro fertilization and embryo transfer in normal weight women: the SUNDRO randomized controlled trial.
A single oral dose of 600,000 IU of vitamin D3 does not improve clinical pregnancy chances in normal weight women with preserved ovarian reserve undergoing IVF cycles.
RCTLarge Human TrialRigorous JournalVitamin D3 metabolite calcidiol primes human dendritic cells to promote the development of immunomodulatory IL-10-producing T cells.
Calcidiol, a vitamin D3 metabolite, is a potent immune modulator that may be more suitable for treating chronic inflammatory diseases than calcitriol due to its less hypercalcimic nature.
In Vitro StudyHigh-dose vitamin D3 c ameliorates renal fibrosis by vitamin D receptor activation and inhibiting TGF-β1/Smad3 signaling pathway in 5/6 nephrectomized rats.
High-dose vitamin D3 treatment improves renal fibrosis in chronic kidney disease by activating the vitamin D receptor and inhibiting the TGF-1/Smad3 signaling pathway in rats.
Non-RCT
Animal StudyRigorous JournalVitamin D3 Is Transformed into 1,25(OH)2D3 by Triggering CYP3A11(CYP3A4) Activity and Hydrolyzing Midazolam
Vitamin D3 increases CYP3A11 activity and reduces midazolam levels in rats, potentially benefiting drug metabolism.
RCTAnimal StudyRigorous JournalVitamin D3-loaded electrospun cellulose acetate/polycaprolactone nanofibers: Characterization, in-vitro drug release and cytotoxicity studies.
This study developed an implantable drug delivery system (IDDS) from electrospun cellulose acetate and polycaprolactone nanofibers, which shows controlled drug release and improved mechanical properties, with no cytotoxicity observed in-vitro.
In Vitro StudyVitamin D and Its Synthetic Analogs
Vitamin D3 supplementation is essential for bone health and autoimmune diseases, and its synthetic analogs offer potential for treating various cancers.
Highly Cited